SEC Form 4 · accession 0001683168-18-000087
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yuichi Iwaki
Officer — President and CEO · Director
Period of report
Jan 6, 2018
Accepted (ET)
Jan 9, 2018 · 6:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.10 | Jan 6, 2018 | A | 450,000 | A | Jan 6, 2018 | Jan 17, 2027 | Common Stock | 450,000 | 450,000 | D |
Explanation of responses
- F1On January 18, 2017, the reporting person was granted an option to purchase 450,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2017. The Performance criteria for 2017 have been met, resulting in full vesting of the option.